SFM
FHTX icon

Sphera Funds Management’s Foghorn Therapeutics FHTX Stock Holding History

Sphera Funds Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.4K Buy
+12,224
New +$67.1K 0.01% 96

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sphera Funds Management's FHTX Position: Q1 2026 in Review

Sphera Funds Management opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 12,224 shares worth $58.4K. The stake represents 0.01% of the portfolio and ranks #96 among its holdings.

105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Sphera Funds Management held 12,224 shares of Foghorn Therapeutics worth $58.4K as of Q1 2026.
  • Foghorn Therapeutics was a new Sphera Funds Management position in Q1 2026.
  • Foghorn Therapeutics made up 0.01% of Sphera Funds Management's portfolio in Q1 2026, its #96 holding.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.